UREA- urea suspension 
Exact-Rx, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Urea Topical Suspension 50%
in a lactic acid & salicylic acid vehicle

For external use only. Not for ophthalmic use. Do not use on eyes, lips or mucous membranes.

DESCRIPTION: Each gram of Urea Topical Suspension 50% contains urea 50% caprylic/capric triglyceride carbomer, cetyl alcohol, edetate disodium, glycerin, hydroxyethylcellulose, lactic acid, linoleic acid, PEG-6, polysorbate 60, propylene glycol, purified water, salicylic acid, sorbitan stearate, titanium dioxide, trolamine, vitamin E and xanthan gum.

UREA is a diamide of carbonic acid with the following chemical structure:

Urea Structural Formula

CLINICAL PHARMACOLOGY: Urea gently dissolves the intercellular matrix, which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, which then softens the hyperkeratotic areas.

PHARMACOKINETICS: The mechanism of action of topically applied urea is not yet known.

INDICATIONS AND USES: For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized, and ingrown nails.

CONTRAINDICATIONS: Known hypersensitivity to any of the listed ingredients.

WARNINGS: For external use only. Avoid contact with eyes, lips or mucous membranes.

PRECAUTIONS: This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.

PREGNANCY: Pregnancy Category B. Animal reproduction studies have revealed no evidence of harm to the fetus; however, there are no adequate and well controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response. Urea Topical Suspension 50% should be given to pregnant women only if clearly needed.

NURSING MOTHERS: It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when Urea Topical Suspension 50% is administered to nursing women.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

ADVERSE REACTIONS: Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the medication.

Call your doctor for medical advice about side effects.

DOSAGE AND ADMINISTRATION: Apply Urea Topical Suspension 50% to affected skin twice per day, or as directed by a physician. Rub in until completely absorbed.

HOW SUPPLIED: Urea Topical Suspension 50%, NDC # 42808-0201-10, is supplied in a 10 oz (283.5 g) tube.

STORAGE: Store at controlled room temperature 15 to 30°C (59 to 86°F).

Protect from freezing.

Manufactured in the U.S.A. for Exact-Rx, Inc., Melville, NY 11747

00-0201-10-205-00

Iss:5/11

PRINCIPAL DISPLAY PANEL - 10 oz (284 g)

For External Use Only

NDC 42808-0201-10        Rx Only

Urea
In a lactic acid & salicylic acid vehicle

50%

SUSPENSION

Exact-Rx.
INCORPORATED

Net Wt. 10 oz (284 g)

Carton

UREA 
urea suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42808-201
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W) UREA500 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CAPRYLIC/CAPRIC MONO/DIGLYCERIDES (UNII: U72Q2I8C85)  
CARBOMER HOMOPOLYMER TYPE C (UNII: 4Q93RCW27E)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCERIN (UNII: PDC6A3C0OX)  
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%) (UNII: S38J6RZN16)  
LACTIC ACID (UNII: 33X04XA5AT)  
LINOLEIC ACID (UNII: 9KJL21T0QJ)  
PEG-6 STEARATE (UNII: 8LQC57C6B0)  
POLYSORBATE 60 (UNII: CAL22UVI4M)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SALICYLIC ACID (UNII: O414PZ4LPZ)  
SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TROLAMINE (UNII: 9O3K93S3TK)  
ALPHA-TOCOPHEROL (UNII: H4N855PNZ1)  
XANTHAN GUM (UNII: TTV12P4NEE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42808-201-101 in 1 CARTON08/01/201108/18/2017
1284 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other08/01/201108/18/2017
Labeler - Exact-Rx, Inc. (137953498)

Revised: 8/2017
 
Exact-Rx, Inc.